ArticleDrug design, development and therapy2025

Tubeimoside I Inhibits the Proliferation of Liver Cancer Through Inactivating NF-κB Pathway by Regulating TNFAIP3 Expression.

Yajun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.